Welcome to our dedicated page for Ormat Tech SEC filings (Ticker: ORA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Geothermal power plants operate for decades, making Ormat Technologies' SEC filings essential reading for understanding long-term contracted revenue. Unlike technology companies with rapidly shifting business models, Ormat's disclosures reveal stable power purchase agreements, plant operating metrics, and equipment order backlogs that shape predictable cash flows.
The company's 10-K annual reports break down performance across the Electricity Segment and Product Segment—two distinct businesses with different risk profiles. Electricity generation provides recurring utility-like revenue, while equipment manufacturing follows a lumpier project-based pattern. Our AI summaries highlight these segment dynamics without requiring you to parse dozens of pages of footnotes.
Ormat's filings contain details investors in other energy sectors might overlook:
- Power purchase agreement terms spanning 20-30 years with contracted pricing structures
- Geothermal resource assessments affecting long-term generation capacity
- Project development pipeline from exploration through commercial operation
- Equipment order backlog indicating future Product Segment revenue
Form 4 insider transactions reveal when executives and directors trade ORA shares. For a company with stable, predictable operations, unusual insider activity can signal material developments before public announcements. Track these filings alongside the company's 8-K disclosures for plant commissioning, acquisition completions, and significant contract announcements.
Quarterly 10-Q reports show seasonal generation patterns and segment performance trends. Our AI explanations translate complex accounting for geothermal development costs, deferred revenue from equipment contracts, and power purchase agreement revenue recognition into straightforward summaries.
ORA: A Form 144 notice discloses a planned sale of 18,018 shares of common stock. The filing lists an aggregate market value of $2,025,666.44, with Morgan Stanley Smith Barney LLC Executive Financial Services as broker. The approximate date of sale is 11/07/2025 on the NYSE.
The shares were acquired as restricted stock from the issuer in three grants: 8,715 on 11/07/2018, 8,715 on 11/07/2019, and 588 on 11/07/2020. As context, 60,781,792 shares were outstanding at the time indicated.
Ormat Technologies (ORA) executive (EVP, Energy Storage & BD) reported insider transactions on 11/05/2025. The reporting person exercised Stock Appreciation Rights (SARs) covering 21,271 shares at an exercise price of $68.34 (expiring 05/12/2026) and 3,300 shares at $71.15 (expiring 03/01/2028).
Following the exercises, the filing shows dispositions tied to the SAR mechanics of 12,640 shares and 2,041 shares at a market value of $115. In addition, 9,890 shares were sold in the open market at $115 pursuant to a Rule 10b5-1 plan adopted on 06/26/2025. After these transactions, the reporting person directly beneficially owned 1,621 shares. The derivative table indicates 1,101 SARs remain beneficially owned.
Form 144 notice discloses a proposed sale of up to 9,890 shares of Common stock through Morgan Stanley Smith Barney LLC. The filing lists an aggregate market value of $1,137,350 and an approximate sale date of 11/05/2025 on the NYSE.
The shares were acquired on 11/05/2025 via Stock Appreciation Rights from the issuer, with cash payment on the same date. Shares outstanding were 60,781,792; this is a baseline figure, not the amount being offered.
Ormat Technologies reported Q3 2025 results with total revenues of $249.7 million versus $211.8 million a year ago. Segment revenues were Electricity $167.1 million, Product $62.2 million, and Energy Storage $20.4 million. Net income attributable to stockholders was $24.1 million (diluted EPS $0.39) versus $22.1 million (diluted EPS $0.36) in Q3 2024. Gross profit was $64.0 million and operating income $40.4 million.
For the nine months, operating cash flow was $230.1 million with capital expenditures of $474.7 million. The company closed the $88.7 million purchase of the 20MW Blue Mountain geothermal plant, which contributed $2.9 million to Electricity revenues and $1.9 million to earnings in Q3. Financing actions included $23.4 million Mammoth Senior Secured Notes (6.95% fixed; amortizing from July 7, 2027; final maturity July 15, 2034), a GB loan facility of up to €99.8 million with related interest rate swaps, and draws of $37.6 million under a $49.8 million Dominica loan. Q3 included $14.4 million of income attributable to sale of tax benefits and $9.6 million of ITC-related tax benefits.
Ormat Technologies, Inc. reported earnings for its third fiscal quarter ended September 30, 2025. The company furnished a press release with detailed results as Exhibit 99.1, which is incorporated by reference.
The disclosure references non-GAAP financial measures, with reconciliations to comparable GAAP metrics provided in the press release. The information in Item 2.02 and Exhibit 99.1 is furnished, not filed, under the Exchange Act.
Insider transaction summary: Ormat Technologies CEO Doron Blachar exercised 45,365 Stock Appreciation Rights (SARs) on 09/29/2025 with an exercise price of $63.40 and a market value of $94.71, resulting in issuance of 14,994 shares. Following these transactions and a concurrent open-market sale, the reporting person beneficially owned 35,419 shares. The SARs exercised were part of awards exercisable from 07/01/2022 and expiring 07/01/2026. The sale of 14,994 shares was executed under a 10b5-1 trading plan adopted 06/30/2025 at a weighted-average price of $94.71.
Insider activity summary: Director Stanley Stern exercised 1,210 stock appreciation rights (SARs) with an exercise price of $76.87, based on SARs that expire November 6, 2025. The exercise used the market value on the exercise date of $94.83 to determine payout, resulting in issuance of 229 common shares and a cash settlement for the remaining economic value equivalent to 981 shares. On the same day, 229 shares were sold at $94.83, and an additional 400 shares were sold on September 30, 2025 at $95.98. After these transactions, Mr. Stern beneficially owned 4,861 shares.
Form 144 notice for Ormat Technologies (ORA): The filing reports a proposed sale of 400 common shares through Morgan Stanley Smith Barney with an aggregate market value of $38,393.84, scheduled approximately on 09/30/2025. The filer states total shares outstanding of 60,723,470. The 400 shares were acquired as restricted stock on 05/08/2025 from the issuer and paid for on that date. The filing also lists two recent dispositions by the same person: 229 shares sold on 09/26/2025 for $21,716.60 and 876 shares sold on 08/27/2025 for $80,578.86. The notice includes the standard Rule 144 attestation that the seller is not aware of undisclosed material adverse information.
Form 144 notice for ORMAT TECHNOLOGIES, INC. (ORA) shows a proposed sale of 5,611 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $531,922.60, with an approximate sale date of 09/29/2025. The filing lists multiple underlying acquisitions: restricted stock grants on various dates in 2023, 2024 and 2025 totaling listed lots (e.g., 288, 313, 519, 393 shares) and a Stock Appreciation Rights award of 3,810 units on 09/29/2025 paid in cash. It also discloses a prior sale on 08/22/2025 of 692 shares for $65,442.44. Several standard signature and representation statements are included.
Form 144 notice for ORMAT TECHNOLOGIES, INC. (ORA) reports a proposed sale of 14,994 common shares on 09/29/2025 through Morgan Stanley Smith Barney LLC on the NYSE. The aggregate market value of the shares is listed as $1,420,153.71 and the issuer’s outstanding shares are shown as 60,723,470. The shares were acquired the same day as Stock Appreciation Rights from the issuer and payment is noted as cash. The filer reports no securities sold in the past three months and attests to lack of undisclosed material adverse information.
FAQ
What is the current stock price of Ormat Tech (ORA)?
What is the market cap of Ormat Tech (ORA)?
